Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT06632587

Timing Impact of Early vs. Late Cranioplasty on Hemicraniectomy Outcomes

Led by Thomas Jefferson University · Updated on 2025-07-23

44

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This prospective, randomized study aims to comprehensively evaluate the impact of cranioplasty timing on postoperative complications and long-term functional outcomes following decompressive hemicraniectomy (DHC). The primary endpoint focuses on comparing the rates of various postoperative complications, including infection, seizures, return to the operating room, and the need for ventriculoperitoneal shunting, between patients undergoing standard of care cranioplasty (\>3 months after DHC) and those receiving early cranioplasty (within 8 weeks).

CONDITIONS

Official Title

Timing Impact of Early vs. Late Cranioplasty on Hemicraniectomy Outcomes

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older at the time of acute traumatic injury or increased intracranial pressure due to stroke or intracranial hemorrhage requiring decompressive hemicraniectomy
  • Cranial flap classified as Craniectomy Contour Class A or B at 4 weeks after surgery
  • Medically optimized for general anesthesia and surgery
Not Eligible

You will not qualify if you...

  • Active systemic infection between weeks 6 and 8 after decompressive hemicraniectomy (e.g., pneumonia, urinary tract infection, soft tissue infection, bacteremia)
  • Cranial infection during the post-decompressive hemicraniectomy period
  • Determined by attending neurosurgeon as not appropriate for early cranioplasty
  • Death before 8 weeks post-injury (acute traumatic injury or brain injury from stroke or intracranial hemorrhage)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Thomas Jefferson University Hospitals

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

Loading map...

Research Team

P

Pious Patel, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here